The diagnostic accuracy of renal vein renin (RVR) analyses was evaluated in 63 hypertensive patients treated with sodium depletion and/or hydralazine prior to selective renal vein sampling. A positive RVR study (i.e., lateralization of RVR) was defined as a ratio ≥ 1.5 when RVR from the kidney with renal artery stenosis was compared to RVR from the contralateral kidney. Approximately 40% of patients with essential hypertension had positive RVR studies. Among patients with renal artery stenosis, surgical outcome was correctly predicted in 5 of 8 patients (63%) treated with sodium depletion, whereas outcome was accurately predicted in 11 of 12 patients (92%) treated with hydralazine. These observations demonstrate that a high percentage of patients with essential hypertension have positive RVR studies despite arteriographically normal renal vasculature. Results obtained in patients with renal artery stenosis suggest that stimulation of renin secretion by hydralazine may be of particular advantage prior to renal vein sampling. However, additional data are required to confirm whether activation of specific mechanisms for renin release improves the reliability of the RVR test.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.